Roheena Panni, MD, MPHS

Surgical Oncologist

Roheena Panni

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Clinical Expertise

  • Bile duct cancer and obstruction, gallbladder cancers, primary liver cancer, metastatic cancer of the liver, and liver tumors, pancreatic cancer and cysts, gastric cancers

Primary Academic Title

Assistant Professor of Surgery, Division of Hepatobiliary Surgery, WashU Medicine

Board Certification

  • 2022: American Board of General Surgery

Training

  • 2014 - 2016: Junior Resident in General Surgery, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
  • 2016 - 2018: Surgical Oncology Research Fellowship, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
  • 2018 - 2020: Senior Resident in General Surgery, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
  • 2020 - 2021: Chief Resident in General Surgery, Barnes-Jewish Hospital, WashU Medicine, St. Louis, MO
  • 2021 - 2023: Complex General Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center. New York, NY
  • 2022 - 2023: Leslie H. Blumgart Fellow, Hepatopancreatobiliary Surgery, Memorial Sloan-Ketering Cancer Center. New York, NY

Education

  • 2011: MBBS, Aga Khan University Medical College, Karachi, Pakistan

Research & Selected Publications

Research Interest

Pancreas cancer, tumor immunology & immunotherapeutics, clinical trials.

Research Publications

DeCAF defines clinical fibroblast subtypes and multidimensional tumor-stroma crosstalk shaping prognosis and immunotherapy response
Authors:

Peng XL, McCabe IC, Kharitonova EV, one or more additional authors omitted Panni RZ, one or more additional authors omitted Yeh JJ

Journal & Year:

Cell Rep Med | 2026

Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer
Authors:

Hogg GD, Weinstein AG, Kingston NL, one or more additional authors omitted Panni RZ, one or more additional authors omitted DeNardo DG

Journal & Year:

Sci Immunol | 2025